Skip to main content
. 2019 Nov 25;20(23):5927. doi: 10.3390/ijms20235927
APD action potential duration
IPoC ischemic postconditioning
PKC protein kinase C
KATP ATP-dependent potassium channels
Cx32 connexin 32
Cx43 connexin 43
CPT adenosine A1 receptor antagonist, cyclopentyl theophylline
SCH adenosine A2A receptor antagonist, SCH 58261
MRS adenosine A3 receptor antagonist, MRS-1523
GLI non selective KATP blocker, glibenclamide
LY Licifer Yellow
RD Rhodamine